Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?

OBJECTIVE. To review the new ultra-rapid-acting insulin analogs and describe the benefits and limitations compared with other bolus insulins. SUMMARY. The options for bolus insulins, which are usually taken at mealtime or for correction of hyperglycemia, are expanding, with recent approvals of faste...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Eva Y., Kroon, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Perspectives in Clinical Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603316/
https://www.ncbi.nlm.nih.gov/pubmed/34866783
http://dx.doi.org/10.2337/cd20-0119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603316/
https://www.ncbi.nlm.nih.gov/pubmed/34866783
http://dx.doi.org/10.2337/cd20-0119

Ejemplares similares